Resources Top 5: Northern Minerals’ Mystery Chinese Investors Told to Sell … Again
The Australian Treasury and the Foreign Investment Review Board have issued a fourth order demanding that Chinese‑linked shareholders divest a combined 17.58% of Northern Minerals (ASX:NTU). Hong Kong Ying Tak Limited reportedly bought an additional 3.79% stake but is barred from voting or selling the shares before July 2. The government has already levied a $14 million penalty on a non‑compliant investor, and NTU’s stock surged 20% on the news. The move is aimed at clearing the register ahead of the Browns Range rare‑earth project’s 2028 production target.
Atara Bounces Back with FDA
Atara Biotherapeutics saw its shares nearly double on May 7 after the FDA outlined a path for resubmitting its cell‑therapy candidate, tabelecleucel. The agency agreed to accept the single‑arm trial data in exchange for additional long‑term follow‑up, easing the regulatory deadlock...
Terrestrial Energy: Projects Progress & DOE Programs Strengthen Commercialization – Quarterly Update Report
Terrestrial Energy’s Integrated Molten Salt Reactor (IMSR) made notable strides in Q1 2026, securing NRC approval of its Postulated Initiating Events (PIE) safety framework and advancing DOE‑backed TETRA and TEFLA pilot programs. A strategic partnership with Riot Platforms opened a data‑center...
BW Offshore: First Quarter Results 2026
BW Offshore reported Q1 2026 EBITDA of $47.9 million and operating cash flow of $43.3 million, supported by a robust liquidity position of $568 million. The company extended the BW Catcher FPSO contract through 2030, adding roughly $490 million to its firm cash‑flow backlog, and...
MannKind Corp. (MNKD) Reports Q1 2026 Total Revenues of $90.2M
MannKind Corp. posted Q1 2026 revenue of $90.2 million, a 15% rise year‑over‑year, driven by $15.5 million in Furoscix sales and higher Tyvaso DPI royalties. R&D expenses jumped 56% to $17.2 million and SG&A surged 116% to $54.1 million after acquiring scPharma and preparing for...
Compass Therapeutics (CMPX) Reports Q1 2026 Net Loss of $18.3M
Compass Therapeutics reported a Q1 2026 net loss of $18.3 million, or $0.10 per share, as R&D expenses rose to $13.4 million and G&A costs jumped 41 percent to $6.9 million. The company ended the quarter with $195 million in cash and marketable securities, extending...
Kristie Batten: Power Putting New Rare Earths Project on the Fast Track
Power Minerals (ASX:PNN) completed a $6 million (≈US$4 million) acquisition of the Morro do Ferro rare‑earth project in Brazil and has appointed rare‑earth specialist Alistair Stephens as CEO. Stephens, who previously drove a small‑cap resource from a $30 million market cap to a...
TRX Gold Corporation (TRX): 10 Best Gold Mining Stocks to Buy as Central Banks Buy Bullion
TRX Gold Corp. posted a strong second‑quarter, swinging to $11.66 million adjusted net income after a prior‑year loss. Production hit a record 7,453 ounces, generating $34.1 million in revenue and a 61% gross margin. Adjusted EBITDA reached $20.2 million, reflecting a 59% margin,...
SEEGNAL INC. ANNOUNCES FILING OF 2025 ANNUAL FILINGS AND THAT THE MCTO WILL NO LONGER BE IN EFFECT AS OF...
Seegnal Inc. announced that the management cease‑trade order (MCTO) affecting its CEO and CFO was lifted on May 16, 2026 after filing audited 2025 financial statements. The order did not restrict public investors and its removal restores full trading ability for the...
Tree Island Steel Announces First Quarter 2026 Results
Tree Island Steel reported Q1 2026 revenue of $40.6 million, down 19% from a year earlier, as U.S. tariffs and the exit from unprofitable lines trimmed sales. Gross profit fell to $2.5 million and adjusted EBITDA slipped to $1.0 million, resulting in a...
Skeena Gold & Silver Reports Q1 2026 Financial Results
Skeena Gold & Silver (TSX: SKE, NYSE: SKE) released its Q1 2026 interim results, confirming that the Eskay Creek gold‑silver project is fully permitted and under construction. The company reaffirmed its target to achieve initial production and cash flow in the...
ProKidney Reports First Quarter 2026 Financial Results and Business Highlights
ProKidney Corp. reported Q1 2026 results, highlighting that its Phase 3 PROACT 1 trial for rilparencel is on schedule to finish enrollment by mid‑2026 with pivotal eGFR‑slope readout expected in Q2 2027. The company disclosed $224.9 million in cash and marketable securities, sufficient to fund...
SharonAI Holdings Inc (USCTF) Q1 2026 Earnings Call Transcript
SoundHound AI reported Q1 2026 revenue of $44.2 million, a 52% year‑over‑year increase, driven by strong automotive and IoT AI growth that rose 88% on an organic basis. GAAP gross margin fell to 31% due to one‑time vendor costs, while non‑GAAP...
Aether Holdings Inc (ATHR) Q2 2026 Earnings Call Transcript
Aehr Test Systems posted Q2 2026 revenue of $9.9 million, a 27% YoY decline, as WaferPak shipments fell and product mix shifted away from high‑margin items. Non‑GAAP gross margin contracted to 29.8% from 45.3%, while cash rose to $31 million following a...
ZSpace, Inc. (ZSPC) Q1 2026 Earnings Call Transcript
Centerspace reported Q1 2026 core FFO of $1.12 per diluted share, with same‑store NOI down 1.1% and revenue flat. Leasing spreads improved, turning positive by March and reaching a preliminary 1.8% in April, while retention rose to 54.1%. Midwest markets,...
SharonAI Holdings Inc (SHAZ) Q1 2026 Earnings Call Transcript
BigBear.ai Holdings reported Q1 2026 revenue of $34.4 million, essentially flat year‑over‑year, while gross margin surged to 34% thanks to higher‑margin generative AI platform revenue from recent acquisitions. Net loss narrowed to $56.8 million, driven by lower interest expense and...
Falcon’s Beyond Reports First Quarter 2026 Financial Results
Falcon’s Beyond Global reported first‑quarter 2026 revenue of $5.4 million, primarily from its Falcon’s Attractions segment and shared‑service fees. The company’s equity‑method investment in Falcon’s Creative Group (FCG) generated $13 million in revenue, a more‑than‑double increase year‑over‑year, and contributed a $0.2 million share...
Full Transcript: Orbit Garant Drilling Q3 2026 Earnings Call
Orbit Garant Drilling reported a record third‑quarter revenue of $51.4 million (≈$38 million USD), a 2.7% year‑over‑year increase, despite severe winter weather and legacy contract pricing pressures. Utilization climbed to 67%, the highest in more than a decade, while the company posted...
Crown Point Announces Operating and Financial Results for the Three Months Ended March 31, 2026
Crown Point Energy reported a strong first‑quarter 2026, with oil and gas sales revenue climbing to $44.5 million on 7,875 BOE per day, more than double the prior year. Net cash from operating activities turned positive at $6.5 million, while operating netback surged to...
Identiv Inc (INVE) Q1 2026 Earnings Call Transcript
Identiv reported Q4 2025 revenue of $6.2 million, beating guidance, while GAAP gross margin surged to 18.1% after completing the shift of RFID production to Thailand. The company secured a multiyear exclusive agreement with IFCO to supply BLE smart labels, positioning...
Leslie's Inc (LESL) Q2 2026 Earnings Call Transcript
Leslie's Inc. reported Q2 2026 net sales of $147.1 million, a 16% year‑over‑year decline, driven by lost hurricane benefits, a 53‑week comparison, and store closures. Gross margin contracted sharply to 18.4% from 27.2% as inventory impairments and lower chemical margins...
Altimmune Inc (ALT) Q1 2026 Earnings Call Transcript
Altimmune reported a strengthened cash position of $274 million, rising to about $340 million pro forma, giving it runway through 2028 to fund its pivotal Phase III PEMB NASH trial. The company disclosed that the trial will enroll roughly 1,800 patients worldwide, with...
Fidelis Insurance Holdings Ltd (FIHL) Q1 2026 Earnings Call Transcript
Fidelis Insurance Holdings posted a record low combined ratio of 79% in Q1 2026, improving by more than eight points year‑over‑year. Operating ROAE climbed to 21.4%, a five‑point increase, while diluted book value per share rose $1.25 to $23.29. Gross...
Longeveron Inc (LGVN) Q1 2026 Earnings Call Transcript
Longeveron secured a $15.9 million private placement, with an optional $15 million milestone tranche, extending its cash runway to the fourth quarter of 2026. The company posted a $22.7 million net loss for 2025, driven by higher personnel, CMC and severance expenses, while...
PACS Strong 1Q Backed by Managed Care Census, Reimbursement, Occupancy Strength Amid the ‘Silver Tsunami’
PACS Group posted a robust first‑quarter 2026, with net income surging to $80.7 million and adjusted EBITDA climbing 75% to $170.4 million. Occupancy rose to 90.9%, far outpacing the industry’s 79% average, driven by higher skilled‑mix admissions and stronger managed‑care contracts. The...
Oklo Earnings Due. This Is What Matters For The Nuclear Startup.
Oklo, a pre‑revenue small modular reactor (SMR) startup, is set to report its Q1 earnings, with analysts forecasting a loss of $0.19 per share, wider than the $0.07 loss a year ago. The company ends 2025 with roughly $1.4 billion in...
A Prudent Play for the Small-Cap Rally
The Russell 2000 has surged more than 16% year‑to‑date, signaling a strong rebound in small‑cap stocks, yet a sizable share of its constituents remain unprofitable. ALPS O’Shares U.S. Small‑Cap Quality Dividend ETF (OUSM) offers a higher‑quality alternative, managing $895.4 million and celebrating its 10‑year anniversary. OUSM emphasizes dividend‑paying,...
Ouster: Ride Robotics Wave
Ouster, Inc. reported a 49% year‑over‑year revenue surge in Q1 2026, powered by record LiDAR sensor shipments and the integration of Stereolabs technology. The company also unveiled the Rev8 native color LiDAR sensor, yet its stock remained flat, valuing the firm...
FESM: Active Small-Cap ETF With Superior Returns And Low Fees
Fidelity’s actively managed Fidelity Enhanced Small‑Cap Core ETF (FESM) has continued to outpace the Russell 2000 and its value and growth sub‑indexes over the past ten years. Using a multi‑factor, bottom‑up approach, the fund delivers superior risk‑adjusted returns while keeping expenses...
Stratec SE ADR (STSEY) Q1 2026 Earnings Call Transcript
Stratec SE reported Q1 2026 revenue of €115 million, a 3% decline year‑over‑year but a 5% rise quarter‑over‑quarter, driven by a solid instrument business that grew 8%. EBIT margin expanded to 12% as cost‑saving measures took effect. The company highlighted a 4%...
Hennge K.K. (HNNGF) Q2 2026 Earnings Call Prepared Remarks Transcript
Japanese cloud‑security provider HENNGE reported solid Q2 FY2026 results, with net sales continuing to rise on the back of its recurring HENNGE One platform. Year‑over‑year gross profit margin improved, reflecting higher average revenue per user. The company also lifted operating...
Bank of America Revamps Nebius Stock Price Target Ahead of Earnings
Bank of America raised its price target on Nebius Group to $205 from $175, keeping a buy rating ahead of the company’s Q1 2026 earnings on May 13. The note highlights two execution metrics: the rollout of data‑center capacity to...
Veteran Analyst Doubles Down on Rocket Lab Stock After Earnings
Veteran analyst Stephen "Sarge" Guilfoyle raised Rocket Lab's price target to $112 after the company posted a record Q1 2026 revenue of $200.3 million, a 63.5% year‑over‑year jump. The earnings beat sparked a 34% one‑day surge, pushing the stock to an...
CT REAL ESTATE INV TRUST Q1 2026 Earnings Call Transcript
CT Real Estate Investment Trust posted a solid Q1 2026, with occupancy at 99.4% and same‑property NOI up 2.3% year‑over‑year. AFFO per unit rose 2.8% and the board approved a 3.5% increase in monthly distributions effective July, the 13th hike since...
Harvard Bioscience Q1 2026 Earnings Call Transcript
Harvard Bioscience posted Q1 2026 revenue of $20.8 million, in line with its $20‑$22 million outlook, and lifted adjusted gross margin to 59%, a 300‑basis‑point year‑over‑year gain. The company highlighted strong sales of its new MeshMEA, BTX electroporation, and SOHO telemetry platforms, which...
Transcript: Super Group (SGHC) Q1 2026 Earnings Conference Call
Super Group (SGHC) posted a record Q1 2026 with revenue of $612 million, up 18% year‑over‑year, and adjusted EBITDA of $152 million, a 36% increase. The company split reporting into Africa and International segments, with Africa revenue rising 33% and International up 9%....
LightInTheBox Holding Reports Q1 2026 Results: Full Earnings Call Transcript
LightInTheBox Holding posted a record first‑quarter profit of $1.2 million, up from $0.1 million a year earlier, while revenue climbed 11% to $52 million, marking its second consecutive quarter of top‑line growth. Branded apparel surged more than 81% year‑over‑year, now representing 24% of...
Buy This Drone Stock as Demand for Unmanned Aircrafts Grows, Goldman Sachs Says
Goldman Sachs has initiated coverage of Aevex, a newly listed drone manufacturer, with a buy rating and a $34 price target, implying roughly 39% upside from the recent close. The company debuted on the NYSE at $20 per share and...
Concentrix (CNXC) Slid Over AI Disruption Concerns
First Pacific Advisors’ Q1 2026 letter highlighted Concentrix Corp (CNXC) as a top‑tier customer‑experience vendor facing AI‑driven disruption. The stock closed at $23.24, down 57.9% over the past year and posted a 1.9% constant‑currency revenue gain to roughly $2.5 billion. The fund...
B2Gold Reports $200M Profit Surge on Strong African Output as Gold Production Reaches 237,763 Ounces
B2Gold Corp. posted a $200 million jump in net income, propelled by robust gold output from its Mali and Namibia operations. The company produced 237,763 ounces in the first quarter, reinforcing its 2025 target of up to 1.075 million ounces. A $325 million sale...
Multibagger Small-Cap Stock Dynamic Cables Plunges 20% After Q4 Results
Dynamic Cables, a multibagger small‑cap, fell 20% to ₹325 (≈ $3.9) on May 12 after reporting modest Q4 results. The quarter showed a 3% YoY net‑profit rise to ₹24 crore (≈ $2.9 million) and a 7% revenue increase to ₹356 crore (≈ $42.7 million). For FY 2025‑26 the company...
Archer Announces 2026 Q1 Results – “USD1.7 Billion in Cash and eIPP Flights This Year”
Archer Aviation reported Q1 2026 cash of $1.78 billion, down $188.8 million from the prior quarter, while revenue rose modestly to $1.6 million. Adjusted EBITDA posted a $172.5 million loss, staying within the company’s $160‑$180 million guidance range. The company completed Phase 3 of the FAA’s...
Shape Australia Signals Strong FY26 with Record Project Wins and Expanding Backlog
Shape Australia (ASX: SHA) announced a bullish FY26 trading update, reporting record project wins of over $0.77 billion USD—already exceeding FY25’s full‑year total. The company’s backlog expanded to more than $449 million USD, and FY26 revenue is forecast between $775 million and $808 million...
Camtek Ltd (CAMT) Q1 2026 Earnings Call Transcript
Camtek reported a record fourth‑quarter revenue of $128.1 million, up 9% year‑over‑year, and full‑year sales of $496.9 million, a 16% increase. Gross margin held steady around 51% while operating margin slipped slightly to 28.6% for the quarter. The company generated $61.2 million of...
Harvard Bioscience Inc (HBIO) Q1 2026 Earnings Call Transcript
Harvard Bioscience reported Q1 2026 results with revenue of $23.7 million, a 3% year‑over‑year decline but a 15% sequential increase. Gross margin rose to 59.7%, the highest in seven quarters, and adjusted EBITDA grew 27% to $3.8 million driven by cost reductions...
Solesence Inc (SLSN) Q1 2026 Earnings Call Transcript
Solésence Inc. reported Q1 2026 revenue of $14.5 million, a 14% YoY decline, and gross margin fell to 23% from 36% due to manufacturing inefficiencies and a shift to a broader product portfolio. The company posted a net loss of $1.1 million...
Arvinas Inc (ARVN) Q1 2026 Earnings Call Transcript
Arvinas reported a steep revenue drop to $9.5 million in Q4, primarily due to the loss of a $40 million Novartis license, while cash fell to just over $85 million. The company cut G&A and R&D expenses, extending its cash runway into 2028,...
Achieve Life Sciences Inc (ACHV) Q1 2026 Earnings Call Transcript
Accendra Health reported Q1 2026 revenue down 6.8%, which would have been flat if not for the exit of a large commercial payor, while adjusted EBITDA hit $58 million, matching internal forecasts. The sleep therapy and urology/ostomy segments each grew over...
NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call Transcript
NeuroOne Medical Technologies reported $2.9 million product revenue for Q1 2026, a 5.5% sequential increase but a decline from the prior year’s $3.3 million due to the absence of license revenue. The 1RF brain‑ablation system accounted for roughly half of all cumulative...
Legend Biotech Corp (LEGN) Q1 2026 Earnings Call Transcript
Legend Biotech reported a blockbuster Q1 2026, with CARVYKTI net trade sales reaching $555 million—a 66% year‑over‑year increase—and total revenue climbing 64% to $306 million. Gross margins held steady at 61% while operating loss shrank 75% to roughly $20 million, delivering a modest...